HOME >> BIOLOGY >> NEWS
Personalized approach to ovarian stimulation achieves high ART pregnancy rates

Lyon, France -- An international group of fertility specialists has developed an easy-to use mathematical formula that allows a personalised approach to ovarian stimulation therapy for women seeking fertility treatment. Clinical tests demonstrated that when clinicians used the formula (or algorithm) to calculate the best starting dose for each patient, both the number of oocytes retrieved and pregnancy rates rose.

Professor Franois Olivennes told the 23rd annual meeting of the European Society of Human Reproduction and Embryology today (Monday 2 July) that the algorithm was based on four factors that predicted ovarian response and that were measured routinely when women were evaluated for fertility treatment: normal (or basal) levels of follicle stimulating hormone (FSH), body mass index, age and the number of small growing (antral) follicles in the ovary detected during screening.

This FSH dose algorithm is simple and easy to use and utilises readily available patient characteristics, said Prof Olivennes, coordinator of the Centre de FIV Eylau La Muette, Paris, France. It is the first to be tested in a prospective multi-national clinical study and it provided each patient with an individualised starting dose of FSH, which could be maintained throughout treatment and resulted in an excellent treatment outcome as testified by the number of oocytes retrieved and the high pregnancy rates.

This approach should enable us to improve patient management, treatment outcomes and safety by reducing the chances of having to either cancel cycles because the ovaries have not been stimulated enough or of ovarian hyperstimulation syndrome (OHSS) developing because the ovaries have been over-stimulated.

Moderate or severe OHSS can occur in 3-8% of IVF cycles [1]. Moderate OHSS can be accompanied by nausea and vomiting. Severe OHSS, which is an uncommon event, can be accompanied by ovarian enlargement and fluid imbalances, sometimes resulti
'"/>

Contact: Emma Mason
wordmason@mac.com
European Society for Human Reproduction and Embryology
2-Jul-2007


Page: 1 2 3

Related biology news :

1. Personalized medicine, future of pharmaceuticals explored in UH lecture
2. Personalized treatments according to type of obesity
3. Researchers use new approach to predict protein function
4. New approach to pulmonary hypertension shows promise
5. New approaches to endometriosis treatment -- mouse experiments point the way
6. Reconstructing the biology of extinct species: A new approach
7. Screening approach leads to discovery of gene linked to breast cancer
8. In new statistical approach, data decide model
9. Bigelow Laboratory Scientists develop new approach to study marine microbes
10. New understanding of schizophrenia could lead to new treatment approaches
11. Cheaper, better disease treatments expected from faster approach to developing antibodies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... , ... September 12, 2018 , ... ... spine fusion solutions announced today it has received 510(k) clearance from the U.S. ... complementing its TowerLOX® MIS Pedicle Screw System. , TowerLOX-EXT MIS Extended Tab Pedicle ...
(Date:9/1/2018)... ... ... is hard at work on his second ocean crossing. After becoming the first human to ... to San Francisco, churning his limbs eight hours a day in the cold Pacific for ... its kind, The Swim is far more than just an extreme sport. Besides the gruelling ...
(Date:8/31/2018)... BELLINGHAM, Wash., and CARDIFF, Wales (PRWEB) , ... ... ... European Space Agency. Martha Sanchez, senior scientist, IBM Research. Jacklyn Novak, infrared materials ... that of Katherine Johnson, the NASA mathematician who just celebrated her 100th birthday. ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... , ... August 28, 2018 , ... ... presenting the results of a safety study performed on an allogeneic (donor derived) ... Veterinary Regenerative Medicine Association (NAVRMA) conference in September. He is also the ...
(Date:8/29/2018)... ... , ... USDM Life Sciences , the leading risk management, technological innovation ... Manu Vohra will deliver a presentation at the BoxWorks 2018 conference in ... GxP in 30 Days” , When: Thursday, August 30, 1:00-1:50 PM PT, Where: ...
(Date:8/26/2018)... ... 24, 2018 , ... ExoCoBio Inc., based in South Korea, ... and inhibits a variety of inflammatory targets in the journal of Stem Cell ... having severe atopic dermatitis were significantly improved after administration of stem cell-derived exosomes ...
(Date:8/23/2018)... WHITEHOUSE STATION, N.J. (PRWEB) , ... August 23, 2018 , ... ... Rutgers University by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the ... few years later. , Visikol’s path from an idea to a successful biotech ...
Breaking Biology Technology:
Cached News: